These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications. Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368 [TBL] [Abstract][Full Text] [Related]
4. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA. Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971 [TBL] [Abstract][Full Text] [Related]
5. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer. Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110 [TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth. Ta HQ; Whitworth H; Yin Y; Conaway M; Frierson HF; Campbell MJ; Raj GV; Gioeli D Mol Cancer; 2019 Jun; 18(1):113. PubMed ID: 31253147 [TBL] [Abstract][Full Text] [Related]
7. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway. Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNAs in prostate cancer: Biological and clinical implications. Das R; Feng FY; Selth LA Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670 [TBL] [Abstract][Full Text] [Related]
9. Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer. Wan X; Huang W; Yang S; Zhang Y; Pu H; Fu F; Huang Y; Wu H; Li T; Li Y Oncotarget; 2016 Sep; 7(37):60503-60518. PubMed ID: 27556357 [TBL] [Abstract][Full Text] [Related]
10. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer. Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429 [TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer. Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592 [TBL] [Abstract][Full Text] [Related]
12. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Crea F; Watahiki A; Quagliata L; Xue H; Pikor L; Parolia A; Wang Y; Lin D; Lam WL; Farrar WL; Isogai T; Morant R; Castori-Eppenberger S; Chi KN; Wang Y; Helgason CD Oncotarget; 2014 Feb; 5(3):764-74. PubMed ID: 24519926 [TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer. Liang Y; Yin W; Cai Z; Luo H; Liu Q; Zhong C; Chen J; Lin Z; Huang Y; Liang Z; Deng J; Zhong W; Cai C; Lu J Hum Genet; 2024 Jul; 143(7):857-874. PubMed ID: 37758909 [TBL] [Abstract][Full Text] [Related]
14. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer. Ye Y; Li SL; Wang SY PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363 [TBL] [Abstract][Full Text] [Related]
15. [Long non-coding RNAs in prostate cancer: An update]. Wu PG; Zhang YX Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435 [TBL] [Abstract][Full Text] [Related]
16. Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer. Chen G; Qin X; Wang Y; Gao B; Ling M; Yin W; Li Y; Pan B Cell Cycle; 2022 Aug; 21(16):1684-1696. PubMed ID: 35414328 [TBL] [Abstract][Full Text] [Related]
17. Identification of androgen response-related lncRNAs in prostate cancer. Karthikeyan SK; Xu N; Ferguson Rd JE; Rais-Bahrami S; Qin ZS; Manne U; Netto GJ; S Chandrashekar D; Varambally S Prostate; 2023 May; 83(6):590-601. PubMed ID: 36760203 [TBL] [Abstract][Full Text] [Related]
18. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms]. Li ZF; Xiao N; Yao YW; Yao ZF Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635 [TBL] [Abstract][Full Text] [Related]
19. LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression. Yao M; Shi X; Li Y; Xiao Y; Butler W; Huang Y; Du L; Wu T; Bian X; Shi G; Ye D; Fu G; Wang J; Ren S Cell Death Dis; 2020 Aug; 11(8):638. PubMed ID: 32801300 [TBL] [Abstract][Full Text] [Related]
20. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management. Ramnarine VR; Kobelev M; Gibb EA; Nouri M; Lin D; Wang Y; Buttyan R; Davicioni E; Zoubeidi A; Collins CC Eur Urol; 2019 Nov; 76(5):546-559. PubMed ID: 31445843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]